NHS cancer jab could mean patients spend hours less in hospital

The introduction of this injectable immunotherapy represents a significant advancement in cancer treatment protocols. By minimizing hospital time, the NHS not only improves patient experience but also optimizes resource allocation, potentially alleviating some of the pressures faced by healthcare facilities. This could mark a pivotal shift in how cancer therapies are administered, emphasizing efficiency and patient-centered care.